246 related articles for article (PubMed ID: 38813652)
1. Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.
Zhang C; Wang Y; Peng J; Wen X; Zhang Y; Li K; Du H; Hu X
Hum Vaccin Immunother; 2024 Dec; 20(1):2355037. PubMed ID: 38813652
[TBL] [Abstract][Full Text] [Related]
2. Research progress on the quality control of mRNA vaccines.
Hu C; Bai Y; Liu J; Wang Y; He Q; Zhang X; Cheng F; Xu M; Mao Q; Liang Z
Expert Rev Vaccines; 2024; 23(1):570-583. PubMed ID: 38733272
[TBL] [Abstract][Full Text] [Related]
3. Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis.
Chen Z; Liu Z; Feng Y; Shi A; Wu L; Sang Y; Li C
Front Immunol; 2024; 15():1259788. PubMed ID: 38426106
[TBL] [Abstract][Full Text] [Related]
4. Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses.
Kutikuppala LVS; Kourampi I; Kanagala RSD; Bhattacharjee P; Boppana SH
Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804384
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer.
Chen Y; Cheng L; Lian R; Song Z; Tian J
Biosci Trends; 2021 May; 15(2):64-73. PubMed ID: 33746182
[TBL] [Abstract][Full Text] [Related]
6. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
7. Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size.
Shi R; Liu X; Wang Y; Pan M; Wang S; Shi L; Ni B
Hum Vaccin Immunother; 2024 Dec; 20(1):2342592. PubMed ID: 38714327
[TBL] [Abstract][Full Text] [Related]
8. Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA.
Zimmermann L; Erbar S
Methods Mol Biol; 2024; 2786():135-144. PubMed ID: 38814392
[TBL] [Abstract][Full Text] [Related]
9. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
[TBL] [Abstract][Full Text] [Related]
10. Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook.
Verma A; Awasthi A
Curr Pharm Des; 2024; 30(14):1049-1059. PubMed ID: 38551046
[TBL] [Abstract][Full Text] [Related]
11. Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis.
Zhang L; Yu K; Zhu B; Mei S; Huo J; Zhao Z
Hum Vaccin Immunother; 2023 Dec; 19(1):2207441. PubMed ID: 37158187
[TBL] [Abstract][Full Text] [Related]
12. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database.
Musa HH; Musa TH
Hum Vaccin Immunother; 2022 Nov; 18(6):2135927. PubMed ID: 36328513
[TBL] [Abstract][Full Text] [Related]
13. Publication trends of research on COVID-19 and host immune response: A bibliometric analysis.
Xia Y; Yao RQ; Zhao PY; Tao ZB; Zheng LY; Zhou HT; Yao YM; Song XM
Front Public Health; 2022; 10():939053. PubMed ID: 36003630
[TBL] [Abstract][Full Text] [Related]
14. Research trends in COVID-19 vaccine: a bibliometric analysis.
Ahmad T; Murad MA; Baig M; Hui J
Hum Vaccin Immunother; 2021 Aug; 17(8):2367-2372. PubMed ID: 33687303
[No Abstract] [Full Text] [Related]
15. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
DiPiazza AT; Leist SR; Abiona OM; Moliva JI; Werner A; Minai M; Nagata BM; Bock KW; Phung E; Schäfer A; Dinnon KH; Chang LA; Loomis RJ; Boyoglu-Barnum S; Alvarado GS; Sullivan NJ; Edwards DK; Morabito KM; Mascola JR; Carfi A; Corbett KS; Moore IN; Baric RS; Graham BS; Ruckwardt TJ
Immunity; 2021 Aug; 54(8):1869-1882.e6. PubMed ID: 34270939
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 mRNA vaccines.
Huang Q; Zeng J; Yan J
J Genet Genomics; 2021 Feb; 48(2):107-114. PubMed ID: 34006471
[TBL] [Abstract][Full Text] [Related]
17. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.
Cao Q; Fang H; Tian H
Biomaterials; 2024 Oct; 310():122628. PubMed ID: 38820767
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.
Narowski TM; Raphel K; Adams LE; Huang J; Vielot NA; Jadi R; de Silva AM; Baric RS; Lafleur JE; Premkumar L
Cell Rep; 2022 Feb; 38(5):110336. PubMed ID: 35090596
[TBL] [Abstract][Full Text] [Related]
19. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
20. The top 100 most cited articles on COVID-19 vaccine: a bibliometric analysis.
Wang W; Wang H; Yao T; Li Y; Yi L; Gao Y; Lian J; Feng Y; Wang S
Clin Exp Med; 2023 Oct; 23(6):2287-2299. PubMed ID: 36939968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
